- Fee assured
- Verified account
- General urology
- Urological oncology
I am a leading prostate cancer surgeon with amongst the highest caseloads for robotic radical prostatectomy in the UK. My NHS practice is at University College London Hospital where I lead the robotic urology team. I have performed the most radical prostatectomies at the highest volume robotic pelvic surgery centre in the UK for each of the past 5 years. I pride myself on my very low complication rate. Since Jan 2018, 600 prostatectomy patients- 0% major complications. I lead an international study of the NeuroSAFE technique.
I continue to consult and treat patents, with appropriate social distancing and precautions, during the COVID-19 pandemic. I also conduct telephone and video consults where preferable.
I have a strong track record of leadership and research in prostate cancer. I lead two national trials designed to investigate ways of improving outcomes for men with prostate cancer. I completed the prestigious Royal College of Surgeons Fellowship in robotic surgery and was trained at Cambridge University where I worked for 5 years as a Lecturer.
I pioneer a technique called NeuroSAFE which is designed to increase the possibility of safe nerve sparing, and therefore sexual potency, after robotic radical prostatectomy. I am leading an NHS funded study testing how effective this technique is.
I am known for my work in scrutinising the way prostate cancer is diagnosed and treated and have featured in front page UK broadsheet headlines and national television news for this work.
I maintain a very low complication rate and blood transfusion rate whilst doing over 4 times the number of robotic radical prostatectomies per year compared to the average of UK prostatectomists. I pride myself on maintaining strong relationships with the patients I treat and many are prepared to talk with people contemplating surgery under my care.
My doctify profile includes patient reviews. https://www.doctify.com/uk/specialist/mr_greg_shaw
I employ the latest techniques to maximise the quality of life for patients undergoing radical prostatectomy.
My work regularly features in the press.
Areas of interest
Prostate Cancer Diagnostics; Prostate cancer; Prostate MRI; Prostate biopsy; Transrectal prostate biopsy, Transperineal prostate biopsy; Targetted prostate biopsy, prostate biopsy for prostate cancer; MRI prostate for prostate cancer; Targeted prostate biopsy for prostate cancer; Transperineal prostate biopsy for accurate prostate cancer mapping; Prostate disease; MRI fusion biopsy
Prostate cancer treatment- Robotic prostatectomy; NeuroSAFE; Frozen section; Retzius sparing; active surveillance; second opinion for prostate cancer options
Urinary problems- Recurrent urinary tract infection; Lower urinary tract symptoms,
Haematuria; Raised PSA; Urinary/urine symptoms; Chronic prostatitis (CP/CPPS); prostatism; urethral stricture; bladder neck stenosis; TURP; BPH; pyelonephritis; Endourology; Kidney stones; ESWL; Urinary stone
Peno-Scrotal Surgery- Circumcision; Vasectomy; Epididymal Cyst; Hydrocele; Orchidectomy; Orchidopexy; Foreskin problem; Phimosis; Pain; Lumps
Current NHS consultant posts held
Lead for Robotic Urology, University College London Hospital
Consultant Urologist UCLH
Consultant Urologist Bartshealth
Honorary Associate Professor UCL
Lead for Urology Research North Thames, NIHR
Maintaining quality of life after prostate cancer surgery.
Nerve sparing and potency after radical prostatectomy.
Keen footballer, jogger and skiier. Avid reader.
Royal College of Surgeons/Rosetrees Foundation, Research Consultant 2021
Prostate cancer UK research grant £600,000 2021
Finalist Health Services Journal Surgical Innovation 2019
JP Moulton Foundation £650,000 research grant 2019
NIHR RfPB award £250,000 2017
Best poster, BAUS 2016
Best Videoposter, BAUS 2015
Best Paper & Best Poster, BAUS 2013
Best Poster, AUA 2013
First Prize, Best Scientific Abstract & Best poster, EAU 2013
(Additional) Languages spoken
- Italian - Conversational
70 peer reviewed articles including:
Tandogdu Z.. Shaw G… Kelly J. Management of patients who opt for radical prostatectomy during the COVID-19 pandemic. BJUi 2020
T Guoa, .. G Shaw, et al The identification of plasma exosomal miR-423-3p as a potential predictive biomarker for prostate cancer castration-resistance development Frontiers in Cell and Developmental Biology 2020
E Dinneen, ... G Shaw. NeuroSAFE frozen section during robot-assisted radical prostatectomy (RARP): Peri-operative and Histopathological Outcomes.BJUi 2020
L Li ,.. G Shaw et al. Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer. Br J Cancer 2020
NeuroSAFE Technique - pathological considerations and practical implications to guide nerve-sparing surgery in prostate cancer patients. E Dinneen,.. GL Shaw, Histopathology 2020
Apparatus for Histological Validation of Magnetic Resonance Imaging of the Human Prostate. Front. Oncol. 2017
PSA screening improves outcome for men with locally advanced and high risk prostate cancer. European Urology 2017
The rapid effects of castration on human prostate cancer. Eur Urol. 2015
Intraoperative frozen section of the prostate to reduces the risk of positive margin whilst ensuring nerve sparing Curr Urol. 2016
Choline kinase alpha is an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target. J Natl Cancer Inst. 2015.
Identification of pathologically insignificant prostate cancer is not accurate in unscreened men. Br J Cancer. 2014
Multinational, Multi-institutional Study Comparing Positive Surgical Margin Rates Among 22,393 Open, Laparoscopic, and Robot-assisted Radical Prostatectomy Patients. Eur Urol. 2013
Shaw GL and Neal D, Chapter 73 The Prostate and Seminal Vesicles. Bailey and Love’s Short Practice of Surgery 27th Edition. 2016
Shaw GL. Neal DE. “Molecular Biology of Prostate cancer”, in Tewari A Prostate Cancer 2011
Courses offered to GPs
NeuroSAFE technique to improve functional outcomes at radical prostatectomy
Advanced prostate cancer diagnostics
Improving diagnostic accuracy in prostate cancer.
Surgery for high risk prostate cancer.
Robotic surgery for improved outcomes in prostate cancer.
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.https://www.baus.org.uk/patients/surgical_outcomes/radical_prostatectomy/surgeon.aspx?id=1409
Performs 150 major robotic cancer operations per year
Highest caseload in largest pelvic urological cancer unit in UK for past 6 years.
Re-admission rate <1% exceptionally low
Post-operative infection rate <5%
0% major complications since start 2018
Mortality rate 0
Patient satisfaction rate >95% (please see doctify page for reviews)
- FRCS (urol) Royal College of Surgeons 2010
- MRCS Royal College of Surgeons of England 2004
- MBBS University of London 1999
- MD Prostate cancer basic research University of London 2006
- Fellowship in Robotic surgery Royal College of Surgeons of England 2014
Reference number 4626222
Details of entry to specialist register
- Urology, 2011
Affiliations / memberships
British Association of Urology
European Association of Urology
Fellow of the Royal College of Surgeons of England
- The London Clinic, W1G 6HL
- 08:00 - 12:30
- 020 7935 4444
- The Princess Grace Hospital, W1U 5NY
- 08:00 - 12:30
- 020 3131 2549
- The Prostate Centre18 Devonshire...
- 13:00 - 17:00
- 020 7407 3100
- The Prostate Centre18 Devonshire...
- 09:00 - 17:00
- 020 7935 9720
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
9-5 mon-fri Private Secretary
Cherelle Mitchell 07841 034453
Out of hours contact the hospital where surgery was performed who are able to contact me.